Table 2.
Clinical features of JAK2 V617F positive liver transplant recipients
| Diagnosis | JAK2 V617F Allele burden (%) | Age | Gender | Hemoglobin (g/dL) | Hematocrit (%) | MCV (ƒL) | WBC count/L | Platelet count/L | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|
|
Alcohol cirrhosis and HCV cirrhosis |
6.71 |
62 |
M |
13.9 |
39.4 |
93.8 |
5.50 x 109 |
250 x 109 |
48 |
|
HCV cirrhosis |
4.25 |
72 |
F |
10.8 |
35.9 |
84.9 |
5.4 x 109 |
213 x 109 |
60 |
|
Budd-Chiari syndrome |
5.65 |
42 |
M |
18.7 |
59.1 |
93.4 |
7.1 x 109 |
234 x 109 |
60 |
| Budd-Chiari syndrome and PV | 8.28 | 41 | F | 10.3 | 23.7 | 86.7 | 23.7x 109 | 282 x 109 | 38 |
HCV, hepatitis C virus; HBV, hepatitis B virus; PVT, portal vein thrombosis; M, male; F, female; MCV, mean corpuscular volume; WBC, white blood cells; PV, polycythemia vera.